1)砂村眞琴,河地茂行,島津元秀:膵癌の疫学.臨床外科67:214-221, 2012
2)Kobari M, Egawa S, Shibuya K, et al:Effect of intraportal adoptive immunotherapy on liver metastases after resection of pancreatic cancer. Br J Surg 87:43-48, 2000
3)Akagawa KS, Takasuka N, Nozaki Y, et al:Generation of CD1+RelB+dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 88:4029-4039, 1996
4)Shimamura S, Sunamura M, Tsuchihara K, et al:Irradiated pancreatic cancer cells undergo both apoptosis and necrosis, and could be phagocytized by dendritic cells. European surgical Research 37:228-234, 2005
5)Cheever MA, Allison JP, Ferris AS, et al:The prioritization of cancer antigens:A national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 15:5323-5337, 2009
6)Soeda A, Morita-Hoshi Y, Makiyama H, et al:Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer. Jpn J Clin Oncol 39:797-806, 2009
7)Kimura Y, Imai K, Shimamura K, et al:Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in the patients with advanced pancreatic carcinoma. Pancreas 41:195-205, 2012